AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...
“Lung disease is the third biggest cause of death in the UK ... exacerbation or ‘flare up’ and will require extra treatment ...
Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
Multiple chemicals in cigarette smoke and e-cigarettes alter the function of a key type of lung immune cell. Cigarette ...
Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.
The study, involving five patients, demonstrated the procedural efficiency and feasibility of AerWave's technology.
A serious health risk affecting your lungs and heart. Whether you're experiencing respiratory distress or seeking preventive ...
Miami (January 9, 2025) – Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is needed to improve holistic patient care ...